# Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study

Source: https://onco.cc/trials/nct07729917/  
OnCo record `nct07729917` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of gemcitabine and oxaliplatin in gallbladder cancer and other biliary tract cancers, run by Zhejiang University, not yet recruiting.

## Summary

Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study is a phase 2 interventional study registered as NCT07729917 by Zhejiang University, with a registry enrolment figure of 240 participants, started 2026-08-10 and due to reach its primary completion in 2028-08-31. Interventions recorded: FGFR Inhibitor, IDH1 mutation inhibitor, KRAS mutation inhibitor, NTRK mutation inhibitor, BRAF V600E mutation inhibitor, BRCA 1/2 mutation inhibitor, HER2 target therapy, Immune Checkpoint Inhibitors, Chemotherapy: GP/GEMOX. Conditions listed: Bile Duct Carcinoma, Cholangiocarcinoma. Gallbladder cancer is named in the registry entry: "* Histologically or cytologically confirmed advanced biliary tract malignancies, including intrahepatic cholangiocarcinoma, extrahepatic cholangiocarcinoma, and gallbladder cancer.". Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: planned
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07729917
- Phase: 2
- Setting: Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study
- Sponsor: Zhejiang University
- Enrolled: 240

## Sources

- ClinicalTrials.gov NCT07729917: https://clinicaltrials.gov/study/NCT07729917

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Extrahepatic cholangiocarcinoma (perihilar and distal)](https://onco.cc/cancers/extrahepatic-cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/), [Intrahepatic cholangiocarcinoma](https://onco.cc/cancers/intrahepatic-cholangiocarcinoma/)
- technologies: [Cytotoxic chemotherapy](https://onco.cc/technologies/cytotoxic-chemotherapy/), [Platinum agents](https://onco.cc/technologies/platinum/)
- drugs: [Gemcitabine](https://onco.cc/drugs/gemcitabine/), [Oxaliplatin](https://onco.cc/drugs/oxaliplatin/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07729917.json